{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T01:43:10Z","timestamp":1778031790271,"version":"3.51.4"},"reference-count":42,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CEOR"],"DOI":"10.2147\/ceor.s265994","type":"journal-article","created":{"date-parts":[[2020,9,13]],"date-time":"2020-09-13T23:55:57Z","timestamp":1600041357000},"page":"505-514","source":"Crossref","is-referenced-by-count":6,"title":["<p>Analysis of the Health and Budgetary Impact of Chondroitin Sulfate Prescription in the Treatment of Knee Osteoarthritis Compared to NSAIDs and COXIBs<\/p>"],"prefix":"10.2147","volume":"Volume 12","author":[{"given":"Carlos","family":"Rubio-Terr\u00e9s","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miguel","family":"Bernad Pineda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Herrero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos","family":"Nieto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dar\u00edo","family":"Rubio-Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2020,9]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"3029","DOI":"10.1185\/03007990802434932","volume":"24","author":"Hochberg","year":"2008","journal-title":"Curr Med Res Opin"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1007\/s00296-009-0969-5","volume":"30","author":"Lee","year":"2010","journal-title":"Rheumatol Int"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"16827","DOI":"10.1038\/srep16827","volume":"5","author":"Zeng","year":"2015","journal-title":"Sci Rep"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1136\/annrheumdis-2014-206792","volume":"75","author":"Hochberg","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1186\/s13075-016-1149-0","volume":"18","author":"Pelletier","year":"2016","journal-title":"Arthritis Res Ther"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1136\/annrheumdis-2016-210860","volume":"76","author":"Reginster","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1007\/s00296-018-4077-2","volume":"38","author":"Simental-Mend\u00eda","year":"2018","journal-title":"Rheumatol Int"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1186\/s13018-018-0871-5","volume":"13","author":"Zhu","year":"2018","journal-title":"J Orthop Surg Res"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"c4675","DOI":"10.1136\/bmj.c4675","volume":"341","author":"Wandel","year":"2010","journal-title":"BMJ"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"c6338","DOI":"10.1136\/bmj.c6338","volume":"341","author":"Giacovelli","year":"2010","journal-title":"BMJ"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"c6328","DOI":"10.1136\/bmj.c6328","volume":"341","author":"Pelletier","year":"2010","journal-title":"BMJ"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"c6335","DOI":"10.1136\/bmj.c6335","volume":"341","author":"Reginster","year":"2010","journal-title":"BMJ"},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"Panel of Experts of the Spanish Society of Rheumatology (SER). First consensus document of the Spanish Society of Rheumatology on the pharmacological treatment of knee osteoarthritis. Reumatol Clin. 2005;1:38\u201348. doi:10.1016\/S1699-258X(05)72711-X","DOI":"10.1016\/S1699-258X(05)72711-X"},{"key":"ref14","first-page":"1","volume":"13","author":"Benito-Ruiz","year":"2012","journal-title":"Sem Fund Esp Reumatol"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1136\/ard.2003.011742","volume":"62","author":"Jordan","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"573","DOI":"10.2165\/00002512-200724070-00005","volume":"24","author":"Bruyere","year":"2007","journal-title":"Drugs Aging"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s40266-019-00662-z","volume":"36","author":"Honvo","year":"2019","journal-title":"Drugs Aging"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.reuma.2016.03.012","volume":"12","author":"Bernad","year":"2016","journal-title":"Reumatol Clin"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1038\/ajg.2012.467","volume":"108","author":"Cryer","year":"2013","journal-title":"Am J Gastroenterol"},{"key":"ref20","unstructured":"Instituto de Investigaci\u00f3n en Atenci\u00f3n Primaria Jordi Gol. Riesgo cardiovascular en pacientes con osteoartritis: estudio de casos y controles. [Cardiovascular risk in patients with osteoarthritis: case-control study]. Code: IJG-M01-2012-01. November 18, 2014."},{"key":"ref21","doi-asserted-by":"publisher","first-page":"e187896","DOI":"10.1001\/jamanetworkopen.2018.7896","volume":"2","author":"Nelson","year":"2019","journal-title":"JAMA Netw Open"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.reuma.2009.12.009","volume":"6","author":"Rubio-Terr\u00e9s","year":"2010","journal-title":"Reumatol Clin"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s40277-016-0066-6","volume":"14","author":"Rubio-Terr\u00e9s","year":"2017","journal-title":"Pharmacoecon Span Res Artic"},{"key":"ref24","first-page":"794","volume":"14","author":"Anguita","year":"2019","journal-title":"Rev Esp Econ Salud"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/j.recesp.2019.06.019","author":"Manito","year":"2019","journal-title":"Rev Esp Cardiol"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"2","DOI":"10.4172\/pe.1000e102","volume":"1","author":"Rubio-Terr\u00e9s","year":"2016","journal-title":"Pharmacoeconomics"},{"key":"ref27","first-page":"31","volume":"9","author":"Rubio-Terr\u00e9s","year":"2017","journal-title":"Clinicoecon Outcomes Res"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/S0210-5705(20)30185-0","volume":"42","author":"Turnes","year":"2019","journal-title":"Gastroenterol Hepatol"},{"key":"ref29","volume-title":"Decision Modelling for Health Economic Evaluation","year":"2006"},{"key":"ref30","volume":"77","author":"Seoane-Mato","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"ref31","unstructured":"INE [Spanish National Statistics Institute]. Poblaci\u00f3n y fen\u00f3menos demogr\u00e1ficos nacionales. Poblaci\u00f3n residente en Espa\u00f1a a 1 de enero, por sexo, edad y a\u00f1o. [Population and national demographic phenomena. Population resident in Spain by sex, age and year]. Available from: http:\/\/www.ine.es\/. Accessed October 14, 2019."},{"key":"ref32","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1093\/rheumatology\/keu403","volume":"54","author":"Wilson","year":"2015","journal-title":"Rheumatol (Oxf)"},{"key":"ref33","unstructured":"CONDROSAN 400 mg hard capsules. CONDROSAN 400 mg granulate for oral solution. Summary of product characteristics. Available from: http:\/\/www.aemps.gob.es\/cima\/pdfs\/es\/ft\/64549\/FT_64549.pdf. Accessed September 17, 2019."},{"key":"ref34","unstructured":"DROGLICAN 200 mg\/250 mg hard capsules. Summary of product characteristics. Available from: http:\/\/www.aemps.gob.es\/cima\/pdfs\/es\/ft\/71394\/FT_71394.pdf. Accessed September 17, 2019."},{"key":"ref35","unstructured":"A trial of GI safety of celecoxib compared with non-selective nonsteroidal antiinflammatory drugs (NSAIDS) (GI-REASONS). Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/results\/NCT00373685?term=GI-REASONS&draw=2&rank=1. Accessed November 21, 2019."},{"key":"ref36","unstructured":"AEMPS [Spanish Agency of Medcines and Medical Devices]. Utilizaci\u00f3n de medicamentos antiinflamatorios no esteroideos en Espa\u00f1a durante el periodo 2013\u20132016. Informe de utilizaci\u00f3n de medicamentos U\/AIN\/V1\/11\/09\/2017. [Use of non-steroidal anti-inflammatory drugs in Spain during the 2013-2016 period. Drug use report U \/ AIN \/ V1 \/ 11\/09\/2017]. Available from: https:\/\/www.aemps.gob.es\/medicamentosUsoHumano\/observatorio\/docs\/antiinflamatorios-AINEs-periodo-2013-2016.pdf. Accessed September 17, 2019."},{"key":"ref37","unstructured":"Catalan Institute of Health. Resolution SLT\/353\/2013 dated 13 February on the revision of public prices corresponding to the health services provided by the Catalan Institute of Health. Official Gazette of the Government of Catalonia; March 1, 2013: 6326."},{"key":"ref38","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1002\/pds.3617","volume":"23","author":"De Abajo","year":"2014","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1111\/jth.12855","volume":"13","author":"Garc\u00eda-Poza","year":"2015","journal-title":"J Thromb Haemost"},{"key":"ref40","unstructured":"ORDER 727\/2017, dated 7 August, of the Regional Minister of Health, setting the public prices for the provision of health services and activities of the network of centres in the Community of Madrid. Official Gazette of the Community of Madrid No. 198;August 21, 2017."},{"key":"ref41","unstructured":"BotPlus. Available from: https:\/\/botplusweb.portalfarma.com\/. Accessed November 21, 2019."},{"key":"ref42","unstructured":"Agrupaci\u00f3n homog\u00e9nea de las presentaciones de los medicamentos para pacientes no hospitalizados que requieren para su dispensaci\u00f3n receta m\u00e9dica oficial u orden de dispensaci\u00f3n, junto con el precio vigente [Homogeneous grouping of the presentations of outpatient medicines that require an official prescription or dispensing order for their dispensing, together with the current price]. Available from: https:\/\/www.mscbs.gob.es\/profesionales\/farmacia\/pdf\/AGRUPACIONES_HOMOGENEAS_MEDICAMENTOS.pdf. Accessed September 17, 2019."}],"container-title":["ClinicoEconomics and Outcomes Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=61391","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=61391","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,13]],"date-time":"2020-09-13T23:56:06Z","timestamp":1600041366000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.dovepress.com\/analysis-of-the-health-and-budgetary-impact-of-chondroitin-sulfate-pre-peer-reviewed-article-CEOR"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":42,"URL":"https:\/\/doi.org\/10.2147\/ceor.s265994","relation":{},"ISSN":["1178-6981"],"issn-type":[{"value":"1178-6981","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9]]}}}